Kentaro Narita

1.5k total citations
96 papers, 677 citations indexed

About

Kentaro Narita is a scholar working on Hematology, Oncology and Molecular Biology. According to data from OpenAlex, Kentaro Narita has authored 96 papers receiving a total of 677 indexed citations (citations by other indexed papers that have themselves been cited), including 51 papers in Hematology, 36 papers in Oncology and 25 papers in Molecular Biology. Recurrent topics in Kentaro Narita's work include Multiple Myeloma Research and Treatments (44 papers), Lymphoma Diagnosis and Treatment (23 papers) and Amyloidosis: Diagnosis, Treatment, Outcomes (14 papers). Kentaro Narita is often cited by papers focused on Multiple Myeloma Research and Treatments (44 papers), Lymphoma Diagnosis and Treatment (23 papers) and Amyloidosis: Diagnosis, Treatment, Outcomes (14 papers). Kentaro Narita collaborates with scholars based in Japan, United States and Netherlands. Kentaro Narita's co-authors include Kosei Matsue, Masami Takeuchi, Daisuke Miura, Akihiro Kitadate, Yoshiaki Abe, Hiroki Kobayashi, Toshiki Terao, Rikako Tabata, Kengo Takeuchi and Tomoko Ikeda‐Fukazawa and has published in prestigious journals such as SHILAP Revista de lepidopterología, Blood and Scientific Reports.

In The Last Decade

Kentaro Narita

86 papers receiving 666 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Kentaro Narita Japan 15 257 246 179 176 147 96 677
Sigal Grisariu Israel 14 239 0.9× 246 1.0× 213 1.2× 161 0.9× 216 1.5× 48 742
Sumana Devata United States 15 175 0.7× 347 1.4× 279 1.6× 144 0.8× 84 0.6× 52 778
Ronit Gurion Israel 17 237 0.9× 381 1.5× 344 1.9× 100 0.6× 110 0.7× 83 830
Beatrice Casadei Italy 14 94 0.4× 294 1.2× 336 1.9× 95 0.5× 125 0.9× 84 662
Fabien Le Bras France 13 140 0.5× 164 0.7× 127 0.7× 249 1.4× 45 0.3× 41 519
Sara Barmettler United States 13 145 0.6× 157 0.6× 128 0.7× 58 0.3× 69 0.5× 44 844
Reinhard Marks Germany 15 423 1.6× 301 1.2× 194 1.1× 136 0.8× 37 0.3× 55 793
Ingrid Kuehnle United States 12 225 0.9× 601 2.4× 155 0.9× 192 1.1× 56 0.4× 15 1.1k
Kazutaka Sunami Japan 18 667 2.6× 530 2.2× 293 1.6× 368 2.1× 87 0.6× 115 1.2k
Francine Garnache‐Ottou France 18 253 1.0× 490 2.0× 225 1.3× 306 1.7× 49 0.3× 54 1.2k

Countries citing papers authored by Kentaro Narita

Since Specialization
Citations

This map shows the geographic impact of Kentaro Narita's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Kentaro Narita with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Kentaro Narita more than expected).

Fields of papers citing papers by Kentaro Narita

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Kentaro Narita. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Kentaro Narita. The network helps show where Kentaro Narita may publish in the future.

Co-authorship network of co-authors of Kentaro Narita

This figure shows the co-authorship network connecting the top 25 collaborators of Kentaro Narita. A scholar is included among the top collaborators of Kentaro Narita based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Kentaro Narita. Kentaro Narita is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
3.
Ishikawa, Tomohiro, et al.. (2024). Dissemination of the Flavivirus Subgenomic Replicon Genome and Viral Proteins by Extracellular Vesicles. Viruses. 16(4). 524–524. 5 indexed citations
4.
Ikeda, Daisuke, Hajime Sakuma, Rikako Tabata, et al.. (2024). Soluble B-cell maturation antigen levels for disease monitoring in oligosecretory and nonsecretory relapsed multiple myeloma. Blood. 145(5). 526–532. 5 indexed citations
5.
Terao, Toshiki, Kentaro Narita, Daisuke Ikeda, et al.. (2023). Clinical Characteristics and Outcomes of Cyclin D1–Positive AL Amyloidosis. American Journal of Clinical Pathology. 160(2). 157–163. 2 indexed citations
6.
Ikeda, Daisuke, Toshiki Terao, Rikako Tabata, et al.. (2023). Analysis of baseline circulating tumor cells integrated with PET/CT findings in transplant-ineligible multiple myeloma. Blood Advances. 8(1). 37–46. 2 indexed citations
7.
Narita, Kentaro, Daisuke Ikeda, Rikako Tabata, et al.. (2023). Safety and efficacy of venetoclax for acute myeloid leukaemia in real-world clinical practice. Japanese Journal of Clinical Oncology. 53(10). 991–995. 2 indexed citations
8.
Tabata, Rikako, et al.. (2022). Brain toxoplasmosis after HLA haploidentical transplantation for acute myeloid leukemia. SHILAP Revista de lepidopterología. 3(3). 1076–1077. 1 indexed citations
9.
Narita, Kentaro, Tomo Suzuki, & Kosei Matsue. (2022). PET/CT imaging of renal intravascular large B-cell lymphoma. Clinical and Experimental Nephrology. 26(11). 1144–1145.
10.
Tabata, Rikako, Toshiki Terao, Daisuke Miura, et al.. (2021). Safety and efficacy of daratumumab in patients with multiple myeloma and severe renal failure. British Journal of Haematology. 193(4). e33–e36. 14 indexed citations
11.
Terao, Toshiki, Youichi Machida, Kentaro Narita, et al.. (2021). Total diffusion volume in MRI vs. total lesion glycolysis in PET/CT for tumor volume evaluation of multiple myeloma. European Radiology. 31(8). 6136–6144. 16 indexed citations
12.
Miura, Daisuke, Kentaro Narita, Rikako Tabata, et al.. (2019). Clinical and Prognostic Impact of (11;14)(q13;q32) Translocation on Patients with Multiple Myeloma. Blood. 134(Supplement_1). 5507–5507. 1 indexed citations
13.
Abe, Yoshiaki, Kentaro Narita, Hiroki Kobayashi, et al.. (2019). 18F-FDG PET/CT-Guided Diagnosis and Evaluation of Treatment Response to Cyclosporine A in Maldistributed Subcutaneous Panniculitis-like T-Cell Lymphoma Without Typical Skin Rash. Clinical Nuclear Medicine. 45(2). e69–e71. 3 indexed citations
14.
Suehara, Yasuhito, Mamiko Sakata‐Yanagimoto, Keiichiro Hattori, et al.. (2017). Liquid Biopsy for the Identification of Intravascular Large B-Cell Lymphoma. Blood. 130. 378–378. 6 indexed citations
15.
Abe, Yoshiaki, Kentaro Narita, Hiroki Kobayashi, et al.. (2017). Normalization of the Serum Free Light Chain Ratio in Patients with Intact Immunoglobulin Multiple Myeloma Who Achieve Less Than Complete Response. Blood. 130. 5380–5380. 1 indexed citations
16.
Narita, Kentaro, Hiroki Kobayashi, Yoshiaki Abe, Masami Takeuchi, & Kosei Matsue. (2017). Evaluation of Risk Factors and Survival Effect of Delayed Excretion of High-Dose Methotrexate in Patients with Leukemia and Lymphoma. Blood. 130. 4132–4132. 2 indexed citations
19.
Abe, Yoshiaki, Yoshiaki Usui, Kentaro Narita, Masami Takeuchi, & Kosei Matsue. (2016). Clinical Features, Diagnosis, and Prognosis of 14 Cases of Neurolymphomatosis: Single Institutional Experience over 10 Years. Blood. 128(22). 3042–3042. 3 indexed citations
20.
Narita, Kentaro, et al.. (1997). [Assessment of surgery for primary lung cancer with dissemination or malignant effusion of pleura (T4 advanced lung cancer)].. PubMed. 50(2). 120–2. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026